nodes	percent_of_prediction	percent_of_DWPC	metapath
Anileridine—Haloperidol—H1F0—hematologic cancer	0.0272	0.613	CrCbGaD
Anileridine—Astemizole—ABCB1—hematologic cancer	0.00566	0.128	CrCbGaD
Anileridine—OPRM1—TCR Signaling Pathway—NFKBIA—hematologic cancer	0.00435	0.00455	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—MTOR—hematologic cancer	0.00435	0.00455	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hematologic cancer	0.00424	0.00444	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—PTPN11—hematologic cancer	0.00414	0.00433	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CXCR4—hematologic cancer	0.00412	0.00431	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—LPAR1—hematologic cancer	0.00411	0.0043	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—FOS—hematologic cancer	0.00402	0.0042	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—CREB1—hematologic cancer	0.00401	0.0042	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL17—hematologic cancer	0.004	0.00419	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCR5—hematologic cancer	0.00393	0.00411	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR2—hematologic cancer	0.00378	0.00395	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—MAP2K1—hematologic cancer	0.00373	0.0039	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—hematologic cancer	0.00365	0.00382	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—PIK3R1—hematologic cancer	0.0035	0.00366	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CXCR4—hematologic cancer	0.00347	0.00364	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCR7—hematologic cancer	0.00347	0.00363	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCL13—hematologic cancer	0.00347	0.00363	CbGpPWpGaD
Anileridine—Pethidine—ALB—hematologic cancer	0.00344	0.0776	CrCbGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—hematologic cancer	0.00325	0.0034	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—TRH—hematologic cancer	0.00323	0.00338	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—hematologic cancer	0.00322	0.00337	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—CD4—hematologic cancer	0.00322	0.00337	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—hematologic cancer	0.00313	0.00327	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—LPAR1—hematologic cancer	0.00313	0.00327	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL1B—hematologic cancer	0.00298	0.00311	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—JUN—hematologic cancer	0.00288	0.00302	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CNR2—hematologic cancer	0.00288	0.00301	CbGpPWpGaD
Anileridine—Haloperidol—ABCB1—hematologic cancer	0.00281	0.0633	CrCbGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—hematologic cancer	0.00276	0.00289	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—MAPK8—hematologic cancer	0.00273	0.00286	CbGpPWpGaD
Anileridine—Fentanyl—ABCB1—hematologic cancer	0.00267	0.0601	CrCbGaD
Anileridine—OPRM1—IL4-mediated signaling events—PIK3CA—hematologic cancer	0.00265	0.00277	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RHOJ—hematologic cancer	0.00264	0.00277	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ARHGEF12—hematologic cancer	0.00259	0.00271	CbGpPWpGaD
Anileridine—Loperamide—ABCB1—hematologic cancer	0.00257	0.0579	CrCbGaD
Anileridine—OPRM1—GPCR downstream signaling—ARHGEF1—hematologic cancer	0.00252	0.00264	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL3—hematologic cancer	0.00247	0.00259	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—PTHLH—hematologic cancer	0.00245	0.00256	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—MAPK3—hematologic cancer	0.00238	0.00249	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—PTGER4—hematologic cancer	0.00238	0.00249	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IFT172—hematologic cancer	0.00236	0.00247	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ARHGEF12—hematologic cancer	0.00235	0.00246	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—TGFB1—hematologic cancer	0.00231	0.00242	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ARHGEF1—hematologic cancer	0.00229	0.0024	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCR5—hematologic cancer	0.00222	0.00232	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—AKT1—hematologic cancer	0.00217	0.00227	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCL2—hematologic cancer	0.00216	0.00226	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PPEF1—hematologic cancer	0.00216	0.00226	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GNA13—hematologic cancer	0.00215	0.00224	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—TIAM1—hematologic cancer	0.00211	0.00221	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCR4—hematologic cancer	0.0021	0.0022	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL17—hematologic cancer	0.00206	0.00215	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—JAK3—hematologic cancer	0.00205	0.00214	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCR5—hematologic cancer	0.00202	0.00211	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL13—hematologic cancer	0.00196	0.00205	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR7—hematologic cancer	0.00196	0.00205	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GNA13—hematologic cancer	0.00195	0.00204	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—TIAM1—hematologic cancer	0.00192	0.00201	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL3RA—hematologic cancer	0.00191	0.002	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—JAK3—hematologic cancer	0.00186	0.00194	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—RGS2—hematologic cancer	0.00184	0.00193	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—TRH—hematologic cancer	0.00182	0.00191	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—TRIO—hematologic cancer	0.00182	0.00191	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—HRAS—hematologic cancer	0.00182	0.00191	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL13—hematologic cancer	0.00178	0.00186	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR7—hematologic cancer	0.00178	0.00186	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—LPAR1—hematologic cancer	0.00177	0.00185	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL6—hematologic cancer	0.00174	0.00182	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL3RA—hematologic cancer	0.00174	0.00182	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HDAC11—hematologic cancer	0.0017	0.00178	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—RGS2—hematologic cancer	0.00168	0.00175	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—TRH—hematologic cancer	0.00166	0.00173	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—TRIO—hematologic cancer	0.00166	0.00173	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BCR—hematologic cancer	0.00163	0.00171	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PDE4B—hematologic cancer	0.00163	0.0017	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CNR2—hematologic cancer	0.00163	0.0017	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—AKT1—hematologic cancer	0.00161	0.00168	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—LPAR1—hematologic cancer	0.0016	0.00168	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—RAC2—hematologic cancer	0.0016	0.00167	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ADCY7—hematologic cancer	0.00153	0.0016	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HDAC10—hematologic cancer	0.00152	0.00159	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CNR2—hematologic cancer	0.00148	0.00154	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PDE4B—hematologic cancer	0.00148	0.00154	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—RAC2—hematologic cancer	0.00145	0.00152	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	0.00145	0.00151	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ARHGEF12—hematologic cancer	0.00139	0.00145	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ADCY7—hematologic cancer	0.00139	0.00145	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PTHLH—hematologic cancer	0.00138	0.00145	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ARHGEF1—hematologic cancer	0.00135	0.00142	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PTGER4—hematologic cancer	0.00135	0.00141	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL3—hematologic cancer	0.00127	0.00133	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PTHLH—hematologic cancer	0.00126	0.00131	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PTGER4—hematologic cancer	0.00122	0.00128	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AGRN—hematologic cancer	0.00121	0.00127	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL17—hematologic cancer	0.00121	0.00127	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCR5—hematologic cancer	0.00119	0.00125	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCR4—hematologic cancer	0.00119	0.00124	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LEF1—hematologic cancer	0.00117	0.00122	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GNA13—hematologic cancer	0.00115	0.0012	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL3—hematologic cancer	0.00115	0.0012	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TIAM1—hematologic cancer	0.00113	0.00118	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—RASGRP1—hematologic cancer	0.00111	0.00116	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL2—hematologic cancer	0.0011	0.00115	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—JAK3—hematologic cancer	0.0011	0.00115	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCR4—hematologic cancer	0.00108	0.00113	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR7—hematologic cancer	0.00105	0.0011	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL13—hematologic cancer	0.00105	0.0011	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL3—hematologic cancer	0.00104	0.00109	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NCOR2—hematologic cancer	0.00104	0.00109	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL3RA—hematologic cancer	0.00103	0.00107	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CRKL—hematologic cancer	0.00103	0.00107	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—RASGRP1—hematologic cancer	0.00101	0.00105	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GRB2—hematologic cancer	0.000997	0.00104	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RGS2—hematologic cancer	0.00099	0.00104	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TRH—hematologic cancer	0.000979	0.00102	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TRIO—hematologic cancer	0.000979	0.00102	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CMA1—hematologic cancer	0.000979	0.00102	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AGO2—hematologic cancer	0.000958	0.001	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SPHK1—hematologic cancer	0.000958	0.001	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HDAC9—hematologic cancer	0.000948	0.000992	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LPAR1—hematologic cancer	0.000948	0.000992	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—H3F3B—hematologic cancer	0.000938	0.000982	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GRB2—hematologic cancer	0.000905	0.000947	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CSF2—hematologic cancer	0.000891	0.000932	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CNR2—hematologic cancer	0.000872	0.000913	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDE4B—hematologic cancer	0.000872	0.000913	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGF19—hematologic cancer	0.000865	0.000905	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—JAK1—hematologic cancer	0.00086	0.0009	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PRKCG—hematologic cancer	0.00086	0.0009	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RAC2—hematologic cancer	0.000858	0.000898	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—DKK1—hematologic cancer	0.000851	0.000891	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STAT5B—hematologic cancer	0.000845	0.000884	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ADCY7—hematologic cancer	0.00082	0.000858	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CSF2—hematologic cancer	0.000809	0.000846	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL2RA—hematologic cancer	0.000803	0.00084	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—XIAP—hematologic cancer	0.000798	0.000835	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—JAK1—hematologic cancer	0.000781	0.000817	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PRKCG—hematologic cancer	0.000781	0.000817	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SH2B3—hematologic cancer	0.000777	0.000813	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SMARCA4—hematologic cancer	0.000777	0.000813	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GZMB—hematologic cancer	0.000773	0.000808	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CTNNA1—hematologic cancer	0.000754	0.000789	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HSPB1—hematologic cancer	0.00075	0.000785	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL3—hematologic cancer	0.00075	0.000785	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—EIF4EBP1—hematologic cancer	0.00075	0.000785	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTHLH—hematologic cancer	0.000742	0.000776	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SDC1—hematologic cancer	0.000742	0.000776	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL2RA—hematologic cancer	0.000729	0.000763	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTGER4—hematologic cancer	0.000722	0.000755	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LCK—hematologic cancer	0.000718	0.000752	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—H3F3A—hematologic cancer	0.000704	0.000737	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRKCZ—hematologic cancer	0.000684	0.000716	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CG—hematologic cancer	0.000669	0.0007	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PARP1—hematologic cancer	0.000661	0.000692	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FBXW7—hematologic cancer	0.00065	0.00068	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HDAC2—hematologic cancer	0.000638	0.000667	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCR4—hematologic cancer	0.000638	0.000667	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CBL—hematologic cancer	0.000621	0.00065	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL3—hematologic cancer	0.000615	0.000643	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CG—hematologic cancer	0.000607	0.000636	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTPN1—hematologic cancer	0.000605	0.000633	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PTPN11—hematologic cancer	0.000597	0.000625	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RASGRP1—hematologic cancer	0.000595	0.000622	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HSP90AA1—hematologic cancer	0.000593	0.00062	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SYK—hematologic cancer	0.000593	0.00062	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000588	0.000615	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CREB1—hematologic cancer	0.000578	0.000605	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STAT1—hematologic cancer	0.000572	0.000598	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL2—hematologic cancer	0.000566	0.000592	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL6R—hematologic cancer	0.000564	0.00059	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000555	0.000581	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—JAK2—hematologic cancer	0.00054	0.000565	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—MAP2K1—hematologic cancer	0.000538	0.000563	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GRB2—hematologic cancer	0.000535	0.00056	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CD—hematologic cancer	0.000534	0.000559	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDGFA—hematologic cancer	0.000534	0.000558	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KITLG—hematologic cancer	0.000526	0.00055	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STAT5A—hematologic cancer	0.000514	0.000538	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000513	0.000536	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CDKN2B—hematologic cancer	0.00051	0.000533	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3R1—hematologic cancer	0.000504	0.000528	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CD86—hematologic cancer	0.000493	0.000516	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—JAK2—hematologic cancer	0.00049	0.000513	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HES1—hematologic cancer	0.000486	0.000509	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	0.000483	0.000506	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CSF2—hematologic cancer	0.000478	0.0005	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGF1—hematologic cancer	0.000478	0.0005	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	0.000471	0.000493	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	0.000471	0.000493	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	0.00047	0.000492	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	0.000465	0.000487	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	0.000463	0.000484	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—JAK1—hematologic cancer	0.000461	0.000483	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	0.000461	0.000483	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	0.000431	0.000451	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL2—hematologic cancer	0.000427	0.000447	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TERT—hematologic cancer	0.000426	0.000446	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	0.000416	0.000435	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TSC2—hematologic cancer	0.000406	0.000425	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	0.000391	0.000409	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	0.000387	0.000405	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ESR1—hematologic cancer	0.00038	0.000397	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FN1—hematologic cancer	0.000375	0.000392	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	0.000371	0.000388	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BAD—hematologic cancer	0.000371	0.000388	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	0.000367	0.000384	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CD80—hematologic cancer	0.00036	0.000376	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KIT—hematologic cancer	0.000359	0.000376	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	0.000359	0.000376	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	0.000359	0.000376	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	0.000353	0.000369	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	0.000344	0.00036	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CREB1—hematologic cancer	0.000342	0.000357	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BRAF—hematologic cancer	0.000337	0.000353	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL2—hematologic cancer	0.000334	0.00035	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL6R—hematologic cancer	0.000333	0.000349	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	0.000333	0.000348	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	0.000318	0.000332	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	0.000315	0.00033	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000312	0.000327	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	0.000309	0.000323	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGF2—hematologic cancer	0.000302	0.000316	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	0.000298	0.000312	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—JAK2—hematologic cancer	0.00029	0.000303	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	0.000284	0.000297	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MDM2—hematologic cancer	0.000283	0.000296	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	0.000275	0.000288	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MTOR—hematologic cancer	0.000275	0.000288	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	0.000263	0.000275	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	0.000258	0.00027	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	0.000255	0.000267	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CASP3—hematologic cancer	0.000253	0.000265	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL2—hematologic cancer	0.000253	0.000264	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL6—hematologic cancer	0.000251	0.000263	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCND1—hematologic cancer	0.000246	0.000258	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—JUN—hematologic cancer	0.000246	0.000257	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	0.000238	0.000249	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTEN—hematologic cancer	0.000238	0.000249	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	0.000232	0.000243	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	0.000232	0.000243	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—EP300—hematologic cancer	0.000227	0.000237	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SRC—hematologic cancer	0.00022	0.000231	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	0.000215	0.000225	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STAT3—hematologic cancer	0.000213	0.000222	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NRAS—hematologic cancer	0.000212	0.000222	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	0.000203	0.000212	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MYC—hematologic cancer	0.000197	0.000207	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	0.000197	0.000206	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KRAS—hematologic cancer	0.000182	0.000191	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	0.000168	0.000175	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TP53—hematologic cancer	0.000162	0.00017	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HRAS—hematologic cancer	0.000155	0.000162	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL6—hematologic cancer	0.000148	0.000155	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AKT1—hematologic cancer	0.000137	0.000143	CbGpPWpGaD
